FibroBiologics Secures European Patent for Cartilage Gene Therapy
Houston, Texas, August 5, 2026 FibroBiologics, Inc. has strengthened its global intellectual property portfolio after the European Patent Office...
oncology innovation
Advertisement
NIH Expands Human Cancer Models for Precision Oncology
Bethesda, Maryland, August 5, 2026 The National Institutes of Health (NIH), through the National Cancer Institute (NCI) and its...
Firefly Bio Acquisition Strengthens J&J Cancer Portfolio
MONTEREY, Calif., July 29, 2026 Johnson & Johnson has completed its $1 billion acquisition of Firefly Bio, Inc., significantly...
Eisai Grants CORE Exclusive Global Oncology Rights
BOSTON, Mass. and TOKYO, Japan, July 28, 2026 CORE Biomedicine has entered into an exclusive global licensing agreement with...
Lupin Spins Out Oncology Pipeline to Kaveri Therapeutics
MUMBAI, India & NAPLES, Fla., July 21, 2026 Lupin Limited has announced the strategic spin-out of two promising clinical-stage...
Advertisements
Hamlet BioPharma Advances Alpha1H into Phase 3 Trial
LUND, Sweden, June 17, 2026 Hamlet BioPharma AB has reached a major clinical development milestone with the successful completion...
Hamlet BioPharma Expands Alpha1H Trial for Bladder Cancer
LUND, Sweden, June 22, 2026 Hamlet BioPharma AB has announced a significant expansion of its U.S. clinical development program...
US WorldMeds Secures Full FDA Approval for TECELRA
LOUISVILLE, Kentucky, June 22, 2026 US WorldMeds has announced that the U.S. Food and Drug Administration (FDA) has granted...
Teva Highlights Long-Term AUSTEDO Success in Tardive Dyskinesia Care
PARSIPPANY, N.J. and TEL AVIV, Israel, June 20, 2026 Teva Pharmaceutical Industries Ltd. has unveiled compelling new long-term data...
Curium Court Victory Clears Path for U.S. GEP-NET Therapy
BOSTON, MA, June 18, 2026 Curium™ has secured a significant legal and commercial milestone after prevailing in a patent...
Advertisement
